Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CGP 7930

Known as: CGP-7930, CGP7930 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
Acute administration of γ-aminobutyric acid (GABA)-B receptor agonists decreases nicotine, cocaine, ethanol, and heroin self… Expand
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • figure 4
Review
2007
Review
2007
CGP7930 (3-(3',5'-Di-tert-butyl-4'-hydroxy)phenyl-2,2-dimethylpropanol) is a positive allosteric modulator of the metabotropic… Expand
2006
2006
GABA systems have been implicated as targets for ethanol at the cellular, molecular and behavioural level. The present study was… Expand
Highly Cited
2005
Highly Cited
2005
We determined the effects of the allosteric gamma-aminobutyric acid B receptor modulators CGP7930 and GS39783 on binding and… Expand
Highly Cited
2005
Highly Cited
2005
The gamma-aminobutyric acidB (GABA(B)) receptor full agonists, baclofen and CGP44532, have been found to suppress different… Expand
Highly Cited
2004
Highly Cited
2004
The γ-aminobutyric acid, type B (GABAB) receptor is well recognized as being composed of two subunits, GABAB1 and GABAB2. Both… Expand
2004
2004
The present study was aimed at assessing the in vivo effectiveness of the positive allosteric modulator of the gamma-aminobutyric… Expand
Highly Cited
2003
Highly Cited
2003
RationalePrevious studies have strongly implicated a role for GABAB receptors in modulating the reinforcing effects of cocaine… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
2003
2003
The ability of 2,6 Di-tert-butyl-4-(-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930), a positive allosteric modulator of GABA(B… Expand
Highly Cited
2001
Highly Cited
2001
The compounds CGP7930 [2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol] and its close analog CGP13501 were identified… Expand
  • figure 3
  • figure 2
  • table 1
  • figure 4
  • figure 5